- Home
- MTRX vs ABEO Comparison
MTRX vs ABEO Comparison
Compare MTRX & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MTRX | ABEO |
|---|---|---|
| Founded | 1984 | 1974 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Engineering & Construction | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 361.0M | 399.5M |
| IPO Year | 1995 | 2005 |
Fundamental Metrics
Financial Performance| Metric | MTRX | ABEO |
|---|---|---|
| Price | $11.18 | $5.96 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | $17.00 | ★ $20.00 |
| AVG Volume (30 Days) | 167.5K | ★ 1.6M |
| Earning Date | 05-06-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 165.16 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $769,286,000.00 | $2,998,000.00 |
| Revenue This Year | $19.75 | $1,024.31 |
| Revenue Next Year | $7.96 | $145.42 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 5.64 | ★ 258.18 |
| 52 Week Low | $9.88 | $4.00 |
| 52 Week High | $15.97 | $7.65 |
Technical Indicators
Market Signals| Indicator | MTRX | ABEO |
|---|---|---|
| Relative Strength Index (RSI) | 37.78 | 41.01 |
| Support Level | $10.79 | $5.00 |
| Resistance Level | $11.74 | $6.07 |
| Average True Range (ATR) | 0.34 | 0.33 |
| MACD | -0.00 | -0.12 |
| Stochastic Oscillator | 4.41 | 15.64 |
Price Performance
Historical ComparisonAbout MTRX Matrix Service Company
Matrix Service Co provides engineering, fabrication, construction, maintenance, and repair services prominently to the energy and industrial markets. The company operates through three main segments: Storage and Terminal Solutions, Utility and Power Infrastructure, and Process and Industrial Facilities. These segments cover services like building and maintaining storage tanks and terminals, supporting power delivery and new power generation projects including renewables, as well as plant maintenance and turnarounds for refining and petrochemical industries. Matrix generates revenue by delivering these services to clients in oil, gas, power, and petrochemical sectors across North America and internationally.
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a commercial-stage biopharmaceutical company. The company is focused on developing cell and gene therapies for life-threatening diseases. The company's ZEVASKYN (prademagene zamikeracel) is an autologous cell-based gene therapy for the treatment of wounds in adults and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB). The company's development portfolio includes adeno-associated virus (AAV)-based gene therapies for ophthalmic diseases with high unmet medical need.